Lange J

ORCID: 0009-0003-8264-0190 · 7 papers in corpus
observational 2026
Nutrients ·doi:10.3390/nu18183010

BACKGROUND/OBJECTIVES: Polyendocrine Metabolic Ovarian Syndrome (PMOS) is a common endocrine disorder affecting women of reproductive age. Current international evidence-based guidelines promote lifestyle management, including diet and nutr…

observational 2025
Contraception and reproductive medicine ·doi:10.1186/s40834-025-00353-8

BACKGROUND: The European Active Surveillance Study of LCS12 (EURAS-LCS12) investigates effectiveness and safety of intrauterine devices (IUDs) in routine clinical practice. Here, we aim to characterise the general population of IUD users ac…

other 2020
Techniques in coloproctology ·doi:10.1007/s10151-020-02211-y
other 2014
Archives of gynecology and obstetrics ·doi:10.1007/s00404-014-3257-x

BACKGROUND: Endometriosis as a benign disease appears frequently in premenopausal women with highly variable symptoms. In advanced stages bowel involvement is common. In symptomatic disease the adequate treatment requires complete resection…

other 2003
Zentralblatt für Gynäkologie ·doi:10.1055/s-2003-42279

OBJECTIVE: Extragenital endometriosis is a rare form of endometriosis. Due to its invasive and metastatic properties it resembles some features of malignant tumours. Cyclooxygenase (COX)-2 is a rate-limiting enzyme in the biosynthesis of pr…

case-report 2002
Zentralblatt für Gynäkologie ·doi:10.1055/s-2002-38912

Endometriosis affects a 10 % of women during their reproductive years. Unequoral statistics concerning the incidence of adenomyosis are not available although a combined occurrence of both diseases is found in a 20 % of cases. The risk that…

case-report 2002
Archives of gynecology and obstetrics ·doi:10.1007/s00404-002-0435-z

Danazol, an inhibitor of pituitary gonadotropin with weak androgenic effect, is currently being used for the treatment of endometriosis. In contrast to other C17 alkylated anabolic steroids, it has been rarely associated with the occurrence…